Target intelligence / Profile preview

Innate DNA sensors

Molecular classification
Pattern recognition receptor, Enzyme, Receptor
01

Overview

Innate DNA sensors represent a specialized class of pattern recognition receptors (PRRs) responsible for detecting double-stranded DNA (dsDNA) in inappropriate cellular compartments, such as the cytosol or endosomes. This group includes key proteins like cyclic GMP-AMP synthase (cGAS), Toll-like receptor 9 (TLR9), and Absent in melanoma 2 (AIM2), which serve as the first line of defense against viral and bacterial infections (Source: PubMed, PMID: 30635666). Upon DNA binding, these sensors activate downstream signaling pathways, primarily the cGAS-STING axis, to induce the expression of Type I interferons and other pro-inflammatory cytokines (Source: Nature Reviews Immunology, 2020). Beyond infection, these sensors play a critical role in detecting self-DNA released during cell death or cellular stress, which can drive autoimmune conditions like systemic lupus erythematosus (SLE) if left unchecked (Source: UniProt). In the context of oncology, therapeutic strategies focus on activating these sensors to turn cold tumors hot by recruiting and activating T cells within the tumor microenvironment (Source: NIH, ClinicalTrials.gov). Conversely, small molecule inhibitors targeting cGAS or STING are under investigation for treating autoinflammatory and neurodegenerative diseases (Source: PubMed, PMID: 32433310). The diversity of these sensors allows the immune system to respond to various DNA sources, including mitochondrial DNA and retrotransposons (Source: Nature, 2013).

Other names
Cytosolic DNA sensorsDNA-sensing pattern recognition receptorsNucleic acid sensorsIntracellular DNA sensors
02

Mechanism of action

Agonism of endosomal or cytosolic sensors to stimulate innate immunity and interferon production; Antagonism to inhibit pathological inflammatory signaling.

03

Biological functions

Immune responseSignal transductionInflammationApoptosisAutophagy
04

Disease associations

InfectionCancerInflammationAutoimmune diseaseNeurodegenerative disease
05

Safety considerations

Cytokine release syndromeSystemic autoimmunityTissue damage from chronic inflammationInjection site reactions
06

Interacting drugs

Tilsotolimod

7 more in the full profile.

07

Biomarkers

Type I Interferon (IFN-alpha/beta)CXCL10 (IP-10)Cyclic GMP-AMP (cGAMP)Interferon-stimulated genes (ISGs)

Beyond the preview

Go deeper on Innate DNA sensors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate DNA sensors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call